139 related articles for article (PubMed ID: 11805176)
1. Apolipoprotein A-IV serum concentrations are elevated in patients with mild and moderate renal failure.
Kronenberg F; Kuen E; Ritz E; König P; Kraatz G; Lhotta K; Mann JFE; Müller GA; Neyer U; Riegel W; Riegler P; Schwenger V; von Eckardstein A
J Am Soc Nephrol; 2002 Feb; 13(2):461-469. PubMed ID: 11805176
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein(a) serum concentrations and apolipoprotein(a) phenotypes in mild and moderate renal failure.
Kronenberg F; Kuen E; Ritz E; Junker R; König P; Kraatz G; Lhotta K; Mann JFE; Müller GA; Neyer U; Riegel W; Riegler P; Schwenger V; VON Eckardstein A
J Am Soc Nephrol; 2000 Jan; 11(1):105-115. PubMed ID: 10616846
[TBL] [Abstract][Full Text] [Related]
3. Association between apolipoprotein A-IV concentrations and chronic kidney disease in two large population-based cohorts: results from the KORA studies.
Stangl S; Kollerits B; Lamina C; Meisinger C; Huth C; Stöckl A; Dähnhardt D; Böger CA; Krämer BK; Peters A; Kronenberg F
J Intern Med; 2015 Oct; 278(4):410-23. PubMed ID: 26037138
[TBL] [Abstract][Full Text] [Related]
4. Role of the kidney in the metabolism of apolipoprotein A-IV: influence of the type of proteinuria.
Lingenhel A; Lhotta K; Neyer U; Heid IM; Rantner B; Kronenberg MF; König P; von Eckardstein A; Schober M; Dieplinger H; Kronenberg F
J Lipid Res; 2006 Sep; 47(9):2071-9. PubMed ID: 16788210
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein A-IV concentrations and clinical outcomes in haemodialysis patients with type 2 diabetes mellitus--a post hoc analysis of the 4D Study.
Kollerits B; Krane V; Drechsler C; Lamina C; März W; Ritz E; Wanner C; Kronenberg F;
J Intern Med; 2012 Dec; 272(6):592-600. PubMed ID: 22891946
[TBL] [Abstract][Full Text] [Related]
6. Low apolipoprotein A-IV plasma concentrations in men with coronary artery disease.
Kronenberg F; Stühlinger M; Trenkwalder E; Geethanjali FS; Pachinger O; von Eckardstein A; Dieplinger H
J Am Coll Cardiol; 2000 Sep; 36(3):751-7. PubMed ID: 10987595
[TBL] [Abstract][Full Text] [Related]
7. Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis.
Attman PO; Alaupovic P
Nephron; 1991; 57(4):401-10. PubMed ID: 2046821
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein A-IV concentrations and cancer in a large cohort of chronic kidney disease patients: results from the GCKD study.
Kollerits B; Gruber S; Steinbrenner I; Schwaiger JP; Weissensteiner H; Schönherr S; Forer L; Kotsis F; Schultheiss UT; Meiselbach H; Wanner C; Eckardt KU; Kronenberg F;
BMC Cancer; 2024 Mar; 24(1):320. PubMed ID: 38454416
[TBL] [Abstract][Full Text] [Related]
9. Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment.
Miller PD; Schwartz EN; Chen P; Misurski DA; Krege JH
Osteoporos Int; 2007 Jan; 18(1):59-68. PubMed ID: 17013567
[TBL] [Abstract][Full Text] [Related]
10. Afamin and apolipoprotein A-IV: novel protein markers for ovarian cancer.
Dieplinger H; Ankerst DP; Burges A; Lenhard M; Lingenhel A; Fineder L; Buchner H; Stieber P
Cancer Epidemiol Biomarkers Prev; 2009 Apr; 18(4):1127-33. PubMed ID: 19336561
[TBL] [Abstract][Full Text] [Related]
11. The relationship between plasma apolipoprotein A-IV levels and coronary heart disease.
Manpuya MW; Guo J; Zhao Y
Chin Med J (Engl); 2001 Mar; 114(3):275-9. PubMed ID: 11780313
[TBL] [Abstract][Full Text] [Related]
12. The impact of protein intake on renal function decline in women with normal renal function or mild renal insufficiency.
Knight EL; Stampfer MJ; Hankinson SE; Spiegelman D; Curhan GC
Ann Intern Med; 2003 Mar; 138(6):460-7. PubMed ID: 12639078
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein A-IV is an independent predictor of disease activity in patients with inflammatory bowel disease.
Broedl UC; Schachinger V; Lingenhel A; Lehrke M; Stark R; Seibold F; Göke B; Kronenberg F; Parhofer KG; Konrad-Zerna A
Inflamm Bowel Dis; 2007 Apr; 13(4):391-7. PubMed ID: 17206692
[TBL] [Abstract][Full Text] [Related]
14. Plasma distribution of apoA-IV in patients with coronary artery disease and healthy controls.
Ezeh B; Haiman M; Alber HF; Kunz B; Paulweber B; Lingenhel A; Kraft HG; Weidinger F; Pachinger O; Dieplinger H; Kronenberg F
J Lipid Res; 2003 Aug; 44(8):1523-9. PubMed ID: 12777472
[TBL] [Abstract][Full Text] [Related]
15. Decreased plasma apolipoprotein A-IV levels in patients with acute coronary syndrome.
Li J; Song M; Qian D; Lu W; Wang J; Jiang G; Jin J; Wu X; Huang L
Clin Invest Med; 2013 Aug; 36(4):E207-15. PubMed ID: 23906492
[TBL] [Abstract][Full Text] [Related]
16. Protection against atherogenesis in mice mediated by human apolipoprotein A-IV.
Duverger N; Tremp G; Caillaud JM; Emmanuel F; Castro G; Fruchart JC; Steinmetz A; Denèfle P
Science; 1996 Aug; 273(5277):966-8. PubMed ID: 8688083
[TBL] [Abstract][Full Text] [Related]
17. Use of angiotensin-converting enzyme inhibitors in patients with heart failure and renal insufficiency: how concerned should we be by the rise in serum creatinine?
Ahmed A
J Am Geriatr Soc; 2002 Jul; 50(7):1297-300. PubMed ID: 12133029
[TBL] [Abstract][Full Text] [Related]
18. Increased serum apoA-IV concentrations in experimental uremic rats.
Seishima M; Torizawa H; Muto Y; Noma A
J Lipid Res; 1992 Oct; 33(10):1441-7. PubMed ID: 1431569
[TBL] [Abstract][Full Text] [Related]
19. Macrovascular disease is associated with increased plasma apolipoprotein A-IV levels in NIDDM.
Vergès BL; Lagrost L; Vaillant G; Petit JM; Cohen M; Gambert P; Brun JM
Diabetes; 1997 Jan; 46(1):125-32. PubMed ID: 8971092
[TBL] [Abstract][Full Text] [Related]
20. Increased serum lipoprotein(a) levels in patients with early renal failure.
Sechi LA; Zingaro L; De Carli S; Sechi G; Catena C; Falleti E; Dell'Anna E; Bartoli E
Ann Intern Med; 1998 Sep; 129(6):457-61. PubMed ID: 9735083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
